Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318

1.

Withdrawn medicines included in the essential medicines lists of 136 countries.

Charles O, Onakpoya I, Benipal S, Woods H, Bali A, Aronson JK, Heneghan C, Persaud N.

PLoS One. 2019 Dec 2;14(12):e0225429. doi: 10.1371/journal.pone.0225429. eCollection 2019.

2.

Medical Devices: Classification and Analysis of Faults Leading to Harms.

Ferner RE, Aronson JK.

Drug Saf. 2019 Nov 5. doi: 10.1007/s40264-019-00879-2. [Epub ahead of print]

PMID:
31691257
3.

Crisis in the supply of medicines.

Ferner RE, Aronson JK, Heneghan C.

BMJ. 2019 Oct 4;367:l5841. doi: 10.1136/bmj.l5841. No abstract available.

PMID:
31585945
4.

Effects of antihypertensives, lipid-modifying drugs, glycaemic control drugs and sodium bicarbonate on the progression of stages 3 and 4 chronic kidney disease in adults: a systematic review and meta-analysis.

Taylor KS, Mclellan J, Verbakel JY, Aronson JK, Lasserson DS, Pidduck N, Roberts N, Fleming S, O'Callaghan CA, Bankhead CR, Banerjee A, Hobbs FR, Perera R.

BMJ Open. 2019 Sep 20;9(9):e030596. doi: 10.1136/bmjopen-2019-030596.

5.

Why reports of clinical trials should include updated meta-analyses.

Heneghan C, Aronson JK.

BMJ Evid Based Med. 2019 Aug 31. pii: bmjebm-2019-111243. doi: 10.1136/bmjebm-2019-111243. [Epub ahead of print] No abstract available.

PMID:
31473599
6.

Key concepts for making informed choices.

Aronson JK, Barends E, Boruch R, Brennan M, Chalmers I, Chislett J, Cunliffe-Jones P, Dahlgren A, Gaarder M, Haines A, Heneghan C, Matthews R, Maynard B, Oxman AD, Oxman M, Pullin A, Randall N, Roddam H, Schoonees A, Sharples J, Stewart R, Stott J, Tallis R, Thomas N, Vale L.

Nature. 2019 Aug;572(7769):303-306. doi: 10.1038/d41586-019-02407-9. No abstract available.

PMID:
31406318
7.

Comparison of essential medicines lists in 137 countries.

Persaud N, Jiang M, Shaikh R, Bali A, Oronsaye E, Woods H, Drozdzal G, Rajakulasingam Y, Maraj D, Wadhawan S, Umali N, Wang R, McCall M, Aronson JK, Plüddemann A, Moja L, Magrini N, Heneghan C.

Bull World Health Organ. 2019 Jun 1;97(6):394-404C. doi: 10.2471/BLT.18.222448. Epub 2019 Apr 4.

8.
9.
10.

Oral hormone pregnancy tests and the risks of congenital malformations: a systematic review and meta-analysis.

Heneghan C, Aronson JK, Spencer E, Holman B, Mahtani KR, Perera R, Onakpoya I.

Version 2. F1000Res. 2018 Oct 31 [revised 2019 Jan 1];7:1725. doi: 10.12688/f1000research.16758.2. eCollection 2018.

11.

Lorcaserin in obesity: minimal benefits and ill-defined harms.

Onakpoya IJ, Aronson JK.

BMJ Evid Based Med. 2019 Aug;24(4):145-146. doi: 10.1136/bmjebm-2018-111128. Epub 2019 Jan 30. Review. No abstract available.

PMID:
30700436
12.

Adverse events in people taking macrolide antibiotics versus placebo for any indication.

Hansen MP, Scott AM, McCullough A, Thorning S, Aronson JK, Beller EM, Glasziou PP, Hoffmann TC, Clark J, Del Mar CB.

Cochrane Database Syst Rev. 2019 Jan 18;1:CD011825. doi: 10.1002/14651858.CD011825.pub2.

PMID:
30656650
13.

Practice variation in the use of tests in UK primary care: a retrospective analysis of 16 million tests performed over 3.3 million patient years in 2015/16.

O'Sullivan JW, Stevens S, Oke J, Hobbs FDR, Salisbury C, Little P, Goldacre B, Bankhead C, Aronson JK, Heneghan C, Perera R.

BMC Med. 2018 Dec 20;16(1):229. doi: 10.1186/s12916-018-1217-1.

14.

Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests.

O'Sullivan JW, Stevens S, Hobbs FDR, Salisbury C, Little P, Goldacre B, Bankhead C, Aronson JK, Perera R, Heneghan C.

BMJ. 2018 Nov 28;363:k4666. doi: 10.1136/bmj.k4666. Erratum in: BMJ. 2019 Jan 29;364:l444.

15.

Reduced Salt Intake for Heart Failure: A Systematic Review.

Mahtani KR, Heneghan C, Onakpoya I, Tierney S, Aronson JK, Roberts N, Hobbs FDR, Nunan D.

JAMA Intern Med. 2018 Dec 1;178(12):1693-1700. doi: 10.1001/jamainternmed.2018.4673.

PMID:
30398532
16.

Sodium valproate: who knew what and when? Cumulative meta-analysis gives extra insights.

Heneghan C, Aronson JK.

BMJ Evid Based Med. 2019 Aug;24(4):127-129. doi: 10.1136/bmjebm-2018-111068. Epub 2018 Oct 22. No abstract available.

PMID:
30348656
17.

Examining the 'psychopharmacology revolution' (1950-1980) through the advertising of psychoactive drugs in the British Medical Journal.

Green AR, Aronson JK, Haddad PM.

J Psychopharmacol. 2018 Oct;32(10):1056-1066. doi: 10.1177/0269881118796810. Epub 2018 Sep 25. Review.

PMID:
30251594
18.

A brief history of clinical evidence updates and bibliographic databases.

Glasziou P, Aronson JK.

J R Soc Med. 2018 Aug;111(8):292-301. doi: 10.1177/0141076818788819. No abstract available.

PMID:
30102098
19.

Prescribing biosimilars.

Aronson JK, Goldacre B, Ferner RE.

BMJ. 2018 Jul 24;362:k3141. doi: 10.1136/bmj.k3141. No abstract available.

PMID:
30042142
20.

Diagnostic test guidelines based on high-quality evidence had greater rates of adherence: a meta-epidemiological study.

O'Sullivan JW, Albasri A, Koshiaris C, Aronson JK, Heneghan C, Perera R.

J Clin Epidemiol. 2018 Nov;103:40-50. doi: 10.1016/j.jclinepi.2018.06.013. Epub 2018 Jul 5.

PMID:
29981871
21.

A word about evidence: 'rapid reviews' or 'restricted reviews'?

Aronson JK, Heneghan C, Mahtani KR, Plüddemann A.

BMJ Evid Based Med. 2018 Dec;23(6):204-205. doi: 10.1136/bmjebm-2018-111025. Epub 2018 Jun 29. No abstract available.

PMID:
29959158
22.

Redefining rapid reviews: a flexible framework for restricted systematic reviews.

Plüddemann A, Aronson JK, Onakpoya I, Heneghan C, Mahtani KR.

BMJ Evid Based Med. 2018 Dec;23(6):201-203. doi: 10.1136/bmjebm-2018-110990. Epub 2018 Jun 27. No abstract available.

PMID:
29950313
23.

The use of mechanistic evidence in drug approval.

Aronson JK, La Caze A, Kelly MP, Parkkinen VP, Williamson J.

J Eval Clin Pract. 2018 Oct;24(5):1166-1176. doi: 10.1111/jep.12960. Epub 2018 Jun 11.

24.

Author Correction: Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net.

O'Sullivan JW, Heneghan C, Perera R, Oke J, Aronson JK, Shine B, Goldacre B.

Sci Rep. 2018 May 24;8(1):8354. doi: 10.1038/s41598-018-26376-7.

25.

What is a 'complex systematic review'? Criteria, definition, and examples.

Mahtani KR, Jefferson T, Heneghan C, Nunan D, Aronson JK.

BMJ Evid Based Med. 2018 Aug;23(4):127-130. doi: 10.1136/bmjebm-2018-110965. Epub 2018 May 19. No abstract available.

PMID:
29778991
26.

Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net.

O'Sullivan JW, Heneghan C, Perera R, Oke J, Aronson JK, Shine B, Goldacre B.

Sci Rep. 2018 Mar 19;8(1):4752. doi: 10.1038/s41598-018-23263-z. Erratum in: Sci Rep. 2018 May 24;8(1):8354.

27.

Marketing medicines: charting the rise of modern therapeutics through a systematic review of adverts in UK medical journals (1950-1980).

Green AR, Haddad PM, Aronson JK.

Br J Clin Pharmacol. 2018 Aug;84(8):1668-1685. doi: 10.1111/bcp.13549. Epub 2018 Mar 25.

28.

Overtesting and undertesting in primary care: a systematic review and meta-analysis.

O'Sullivan JW, Albasri A, Nicholson BD, Perera R, Aronson JK, Roberts N, Heneghan C.

BMJ Open. 2018 Feb 11;8(2):e018557. doi: 10.1136/bmjopen-2017-018557. Review.

29.

Benefits and Harms in Pivotal Trials of Oral Centrally Acting Antiobesity Medicines: A Systematic Review and Meta-Analysis.

Onakpoya IJ, Collins DRJ, Bobrovitz NJH, Aronson JK, Heneghan CJ.

Obesity (Silver Spring). 2018 Mar;26(3):513-521. doi: 10.1002/oby.22118. Epub 2018 Feb 5. Review.

30.

Overdiagnosis: what it is and what it isn't.

Brodersen J, Schwartz LM, Heneghan C, O'Sullivan JW, Aronson JK, Woloshin S.

BMJ Evid Based Med. 2018 Feb;23(1):1-3. doi: 10.1136/ebmed-2017-110886. No abstract available.

PMID:
29367314
31.

Non-existent authors.

Aronson JK.

BMJ. 2017 Dec 13;359:j5706. doi: 10.1136/bmj.j5706. No abstract available.

PMID:
29237602
32.

Transvaginal mesh failure: lessons for regulation of implantable devices.

Heneghan C, Aronson JK, Goldacre B, Mahtani KR, Plüddemann A, Onakpoya I.

BMJ. 2017 Dec 7;359:j5515. doi: 10.1136/bmj.j5515. No abstract available.

PMID:
29217786
33.

Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.

Heneghan CJ, Goldacre B, Onakpoya I, Aronson JK, Jefferson T, Pluddemann A, Mahtani KR.

BMJ Open. 2017 Dec 6;7(12):e017125. doi: 10.1136/bmjopen-2017-017125. Review.

34.

Journal Clubs: 2. Why and how to run them and how to publish them.

Aronson JK.

Evid Based Med. 2017 Dec;22(6):232-234. doi: 10.1136/ebmed-2017-110861. Epub 2017 Nov 17. No abstract available.

PMID:
29150551
35.

Journal Clubs: 1. Origins.

Aronson JK.

Evid Based Med. 2017 Dec;22(6):231. doi: 10.1136/ebmed-2017-110860. Epub 2017 Nov 17. No abstract available.

PMID:
29150550
36.

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review.

Onakpoya IJ, Heneghan CJ, Aronson JK.

Expert Opin Drug Saf. 2018 Jan;17(1):63-72. doi: 10.1080/14740338.2018.1398232. Epub 2017 Nov 1. Review.

PMID:
29076385
37.

Unlicensed and off-label uses of medicines: definitions and clarification of terminology.

Aronson JK, Ferner RE.

Br J Clin Pharmacol. 2017 Dec;83(12):2615-2625. doi: 10.1111/bcp.13394. Epub 2017 Sep 26. Review.

38.

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.

Onakpoya IJ, Heneghan CJ, Aronson JK.

Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1328-1337. doi: 10.1002/pds.4256. Epub 2017 Jul 9. Review.

PMID:
28691251
39.

The toxicological significance of post-mortem drug concentrations in bile.

Ferner RE, Aronson JK.

Clin Toxicol (Phila). 2018 Jan;56(1):7-14. doi: 10.1080/15563650.2017.1339886. Epub 2017 Jul 6. Review.

PMID:
28681613
40.

Drugs for rare disorders.

Cremers S, Aronson JK.

Br J Clin Pharmacol. 2017 Aug;83(8):1607-1613. doi: 10.1111/bcp.13331. Epub 2017 Jun 27.

41.

CARE guidelines for case reports: explanation and elaboration document.

Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, Kiene H, Helfand M, Altman DG, Sox H, Werthmann PG, Moher D, Rison RA, Shamseer L, Koch CA, Sun GH, Hanaway P, Sudak NL, Kaszkin-Bettag M, Carpenter JE, Gagnier JJ.

J Clin Epidemiol. 2017 Sep;89:218-235. doi: 10.1016/j.jclinepi.2017.04.026. Epub 2017 May 18.

PMID:
28529185
42.

Post-marketing drug withdrawals: Pharmacovigilance success, regulatory problems.

Aronson JK.

Therapie. 2017 Oct;72(5):555-561. doi: 10.1016/j.therap.2017.02.005. Epub 2017 Mar 30.

PMID:
28461037
43.

Biomarkers-A General Review.

Aronson JK, Ferner RE.

Curr Protoc Pharmacol. 2017 Mar 17;76:9.23.1-9.23.17. doi: 10.1002/cpph.19. Review.

PMID:
28306150
44.

Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification.

Onakpoya IJ, Heneghan CJ, Aronson JK.

Drug Saf. 2017 May;40(5):431-441. doi: 10.1007/s40264-017-0515-4.

PMID:
28238125
45.

Poor medication adherence in clinical trials: consequences and solutions.

Breckenridge A, Aronson JK, Blaschke TF, Hartman D, Peck CC, Vrijens B.

Nat Rev Drug Discov. 2017 Mar;16(3):149-150. doi: 10.1038/nrd.2017.1. Epub 2017 Feb 3.

PMID:
28154411
46.
47.
48.
49.

Short- and medium-term effects of light to moderate alcohol intake on glycaemic control in diabetes mellitus: a systematic review and meta-analysis of randomized trials.

Hirst JA, Aronson JK, Feakins BG, Ma C, Farmer AJ, Stevens RJ.

Diabet Med. 2017 May;34(5):604-611. doi: 10.1111/dme.13259. Epub 2016 Oct 13. Review.

PMID:
27588354
50.

"Collaborative care" is preferable to "patient centred care".

Aronson JK; consultant physician and clinical pharmacologist.

BMJ. 2016 May 26;353:i2926. doi: 10.1136/bmj.i2926. No abstract available.

PMID:
27230429

Supplemental Content

Loading ...
Support Center